A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

@article{Seyfarth2008ARC,
  title={A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.},
  author={Melchior Seyfarth and Dirk Sibbing and Iris Bauer and Georg Fr{\"o}hlich and Lorenz Bott-Fl{\"u}gel and Robert Byrne and Josef Dirschinger and Adnan Kastrati and Albert Schoemig},
  journal={Journal of the American College of Cardiology},
  year={2008},
  volume={52 19},
  pages={1584-8}
}
OBJECTIVES The aim of this study was to test whether the left ventricular assist device (LVAD) Impella LP2.5 (Abiomed Europe GmbH, Aachen, Germany) provides superior hemodynamic support compared with the intra-aortic balloon pump (IABP). BACKGROUND Cardiogenic shock caused by left ventricular failure is associated with high mortality in patients with acute myocardial infarction (AMI). An LVAD may help to bridge patients to recovery from left ventricular failure. METHODS In a prospective… CONTINUE READING
Highly Influential
This paper has highly influenced 20 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
190 Citations
8 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 190 extracted citations

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Similar Papers

Loading similar papers…